Guidance

Live attenuated flu vaccine: patient group direction (PGD) template

PGD template to support the administration of live attenuated flu vaccine (Fluenz Trivalent®) in accordance with national seasonal flu vaccination programme

• From: UK Health Security Agency
• Published: 10 July 2024
• Last updated: 13 August 2025 — See all updates

Applies to England

Documents

Influenza vaccine (Fluenz Trivalent®): patient group direction (PGD) template

MS Word Document, 1.43 MB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Addendum to: live attenuated influenza vaccine nasal spray suspension (LAIV) patient group direction (PGD)

MS Word Document, 155 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This PGD template supports the administration of live attenuated influenza vaccine (LAIV) (Fluenz Trivalent®) as part of the national seasonal influenza vaccination programme.

LAIV PGD version 15.00 is valid from 1 September 2025 to 1 April 2026.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012).

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of product characteristics for the vaccine.

Published 10 July 2024

Last updated 13 August 2025 + show all updates

1. 13 August 2025

   Added information about the addendum.

2. 8 August 2025

   Added 'Addendum to: Live attenuated influenza vaccine nasal spray suspension (LAIV) Patient Group Direction (PGD)'

3. 1 July 2025

   Added version 15, see page 4 for change history.

4. 10 July 2024

   First published.